TalkMed Clarifies Acquisition Discussions Still 'Ongoing'
TalkMed Group Confirms Continued Negotiations for Potential Stake Sale; Shares Up 3%
TalkMed Group Limited's (SGX:5G3) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Calculating The Intrinsic Value Of TalkMed Group Limited (SGX:5G3)
TakMed Still in Discussions With Interested Parties for Acquisition of Stake in Company
TalkMed Group Advises Shareholder Caution Amidst Acquisition Talks
TalkMed Completes Disposal Hong Kong Integrated Oncology Centre
With a 85% Stake, TalkMed Group Limited (SGX:5G3) Insiders Have a Lot Riding on the Company
TalkMed Advances CAR-T Therapy Manufacturing
TalkMed Group Advises Caution Amidst Acquisition Talks
Investors Met With Slowing Returns on Capital At TalkMed Group (SGX:5G3)
TalkMed: Financial Statements and Related Announcement-Half Yearly Results
TalkMed Continues Preliminary Discussions Over Acquisition
TalkMed's Subsidiary Enters Sale and Purchase Agreement to Dispose Shares in Unit
TalkMed in Preliminary Acquisition Talks
TalkMed Group Cautions Shareholders Amid Acquisition Talks
Investors in TalkMed Group (SGX:5G3) Have Unfortunately Lost 5.0% Over the Last Five Years
TalkMed Group Hosts 11th Annual General Meeting
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal
TalkMed Group Settles High Court Litigation
No Data
No Data